MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a strong global intellectual property portfolio supporting lead ...

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Your endocrine system regulates many bodily functions, from ...

OPKO Health, Entera Bio expand collaboration and license agreement to advance the first oral long-acting PTH analog: Miami Friday, February 6, 2026, 12:00 Hrs [IST] OPKO Health In ...

A clinical-stage biopharmaceutical company focused on obesity and weight management, with a pipeline of injectable and oral ...

Healthtech startup Elevate Now has raised ₹18 Cr in a seed round led by Physis Capital, with participation from IPV and Titan ...

This is the third program that successfully combines Entera's oral peptide N-Tab- platform with OPKO's advanced protein chemistry capabilities The companies have accelerated this program and aim to ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

MEDVi has a physician-monitored telehealth platform that enables patients to receive GLP-1 weight loss therapy through linking with licensed clinicians, compounded drugs via licensed pharmacies and ...

Left untreated, obstructive sleep apnea (OSA) can have short- and long-term effects on your brain, from memory and learning to cognitive functions.

This article discusses the best long-term stocks to considering buying right now.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.